AR MPJE cheat sheet

Federal legend drugs require a prescription unless exempted by the FDCA; Arkansas adopts federal legend status and adds state labeling and recordkeeping duties.

Arkansas is an FDA-authorized state for drug wholesaling; wholesale distributors and third-party logistics providers must be licensed by the Arkansas Board of Pharmacy.

Drugs dispensed in Arkansas must bear a label with pharmacy name and address, prescription number, date, patient name, prescriber name, directions, and drug name and strength.

The federal Combat Methamphetamine Epidemic Act limits retail sales of ephedrine/pseudoephedrine: 3.6 g per day and 9 g per 30 days per purchaser, with logbook and ID requirements.

Arkansas requires reporting of theft or significant loss of controlled substances to the Board of Pharmacy and DEA; federal DEA Form 106 is used for theft or significant loss.

Manufacturers and repackagers must provide a pedigree/transaction documentation for prescription drugs under the DSCSA; Arkansas enforces DSCSA compliance for in-state licensees.

Federal law prohibits refilling a prescription for a Schedule III or IV drug more than five times within six months of the issue date; Arkansas follows the federal limitation.

Arkansas pharmacist licensure requires graduation from an ACPE-accredited program, passing NAPLEX and MPJE, and completion of intern hours as set by the Board.

Arkansas pharmacy technician registration requires Board application; technicians must work under a pharmacist's direct supervision and may not perform final verification of a prescription.

A Arkansas pharmacy license is issued per physical location; a change of location, ownership, or name requires notification or a new license application to the Board.

Pharmacist licenses in Arkansas renew biennially; continuing education includes a Board-specified number of hours with required topics such as pharmacy law and patient safety.

Grounds for discipline in Arkansas include fraud, unprofessional conduct, impairment, and dispensing without a valid prescription; sanctions range from reprimand to revocation.

The Arkansas Board of Pharmacy may issue a temporary or emergency license and may summarily suspend a license when public health or safety is threatened.

Nonresident pharmacies that ship prescription drugs to Arkansas patients must register with the Arkansas Board of Pharmacy and comply with Arkansas labeling and counseling rules.

A valid prescription must include patient name, drug name, strength, dosage form, quantity, directions, prescriber name and address, and date of issue.

Arkansas permits electronic prescriptions for controlled substances when the prescriber and pharmacy use DEA-compliant systems with identity proofing and two-factor authentication.

A pharmacist may dispense an emergency oral Schedule II prescription only if the prescriber provides a written prescription within seven days; otherwise the pharmacist must notify DEA.

Refills are not permitted on Schedule II prescriptions; partial fills are allowed under federal rules for Schedule II when the pharmacist cannot supply the full quantity, with the remainder dispensed within 72 hours.

Arkansas requires patient counseling by a pharmacist or intern on new prescriptions unless the patient declines; counseling may be provided in person or by telephone.

Substitution of a therapeutically equivalent generic drug is permitted unless the prescriber writes 'dispense as written' or the patient requests the brand; Arkansas requires notification of substitution.

Prescription records in Arkansas must be retained for at least two years and be readily retrievable for inspection by the Board.

Federal schedules: Schedule I has no accepted medical use; Schedule II has high abuse potential with accepted medical use; III, IV, and V have decreasing abuse potential.

A DEA registration is required for each principal place of business where controlled substances are dispensed, stored, or distributed; registration must be renewed every three years.

Schedule II records must be kept separately from other records; all controlled substance records must be maintained for two years and be available for inspection.

A DEA Form 222 (or CSOS electronic equivalent) is required to order Schedule I or II controlled substances; the form must be completed and retained by the supplier and purchaser.

A physical inventory of controlled substances must be taken every two years on the registrant's inventory date, with exact counts for Schedule II and estimated counts allowed for III-V.

Schedule V drugs may be sold without a prescription only under state law conditions; Arkansas requires the purchaser to be at least 18 and requires a logbook for certain products.

Transfer of controlled substance prescriptions between pharmacies: Schedule III-V prescriptions may be transferred once, with documentation; Schedule II prescriptions may not be transferred under federal rules.

Arkansas pharmacies must maintain a policy and procedure manual covering dispensing, recordkeeping, and quality assurance, reviewed annually.

Records of receipt and distribution of prescription drugs must be retained for two years in Arkansas and be retrievable within a reasonable time for Board inspection.

A perpetual inventory or equivalent system is required for controlled substances; discrepancies must be investigated and documented.

Expired or unusable drugs must be segregated and disposed of according to federal and Arkansas environmental and controlled substance rules.

Pharmacies must maintain a current list of responsible persons and report changes in the pharmacist-in-charge to the Arkansas Board of Pharmacy.

Continuous quality improvement programs are required in Arkansas pharmacies to track and analyze medication errors and dispensing errors.

Pharmacists must counsel on new prescriptions and offer counseling on refills; counseling includes drug name, directions, precautions, and significant side effects.

Patient profiles must include allergies, current medications, and diagnoses when available; pharmacists must screen for drug interactions and duplicative therapy.

Medication error reporting in Arkansas is encouraged through the Board and national reporting systems; serious errors must be documented and reviewed.

Pharmacists have a duty to warn or counsel when a prescription appears inappropriate; they may refuse to fill and must document the refusal.

Arkansas requires the use of safety packaging and child-resistant containers unless the patient or prescriber requests otherwise.

Confidentiality of patient records is required under HIPAA and Arkansas law; records may be released only with patient authorization or as required by law.

Arkansas pharmacists may administer vaccines to patients of specified ages under a statewide protocol or prescription; the Board sets training and reporting requirements.

Vaccine administration must be documented in the Arkansas Immunization Information System (AR-IIS) as required by state law.

Pharmacists may enter into collaborative practice agreements with prescribers to manage drug therapy under Arkansas Board rules; the agreement must define scope and protocols.

Arkansas pharmacists may dispense naloxone under a standing order or protocol to reduce opioid overdose deaths.

Pharmacists must report adverse events following immunization to the Vaccine Adverse Event Reporting System (VAERS).

Emergency contraception and certain self-administered hormonal contraceptives may be dispensed by pharmacists under Arkansas protocols subject to Board rules.

The FDCA defines prescription drugs and requires them to be dispensed only on a prescription; Arkansas law incorporates federal legend drug requirements.

Arkansas requires a prescription drug order to include the prescriber's DEA number for controlled substances and the prescriber's license number for other legend drugs.

The federal Controlled Substances Act and Arkansas Uniform Controlled Substances Act both apply; the stricter requirement controls.

Arkansas prohibits the dispensing of prescription drugs without a valid patient-practitioner relationship; telemedicine prescribing must meet Arkansas standards.

Drug samples may be distributed only by licensed prescribers or their designees; Arkansas pharmacies may not dispense samples as prescription fills.

Arkansas requires reporting of suspicious orders of controlled substances by distributors to the Board and DEA.

Arkansas pharmacist license renewal requires completion of continuing education including a specified number of hours in pharmacy law and patient safety.

The Arkansas Board of Pharmacy may deny, suspend, or revoke a license for violations including dispensing errors, fraud, and failure to maintain records.

Pharmacy interns must be enrolled in an accredited pharmacy program and registered with the Board; intern hours must be documented.

A pharmacy technician may not counsel patients, perform final verification, or administer immunizations unless separately certified and authorized.

Change of pharmacist-in-charge must be reported to the Arkansas Board within a specified time and the new PIC must be licensed in Arkansas.

The Board may conduct inspections and require corrective action plans for deficiencies; failure to comply may result in discipline.

A prescription for a controlled substance must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice.

Arkansas requires that a prescription be reduced to writing or transmitted electronically; oral prescriptions are permitted for non-controlled drugs and certain controlled drugs as allowed by federal law.

The pharmacist must verify the prescription's authenticity and the prescriber's authority before dispensing; questionable prescriptions require prescriber contact and documentation.

Labels for controlled substances must include the federal transfer warning: 'Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed.'

Arkansas requires that prescriptions be filed and retained in a manner that allows retrieval by patient name, drug name, and prescriber.

A pharmacist may provide a partial fill of a Schedule II prescription when requested by the patient or prescriber; the remainder must be dispensed within 72 hours or the prescription is void.

Schedule II prescriptions must be written, electronic, or oral in emergency situations; oral Schedule II prescriptions require a written follow-up within seven days.

Schedule III and IV prescriptions may be refilled up to five times within six months of the date of issue; Schedule V refills are limited by state law.

DEA Form 41 is used to document destruction of controlled substances; destruction must be witnessed and records retained for two years.

Theft or significant loss of controlled substances must be reported to DEA in writing within one business day of discovery, using DEA Form 106.

A DEA registrant must maintain a biennial inventory and keep records of controlled substances received, dispensed, and destroyed for two years.

Arkansas requires that controlled substance prescriptions be filed separately from other prescriptions; Schedule II prescriptions must be filed separately from III-V.

Arkansas pharmacies must have a designated pharmacist-in-charge responsible for compliance with all laws and rules.

Records must be maintained for at least two years and be available for inspection by the Board during business hours.

Controlled substance inventories must be conducted biennially and whenever there is a change in the pharmacist-in-charge or ownership.

Pharmacies must maintain a current list of all personnel and their registration status with the Board.

Automated dispensing systems must meet Board requirements for security, recordkeeping, and accountability.

Pharmacy records may be maintained electronically if they are readily retrievable and a backup system is in place.

Patient counseling must be provided by a pharmacist or a pharmacist intern under supervision; technicians may not counsel.

Counseling must include the name and description of the drug, dosage form, route, duration, special directions, and precautions.

Pharmacists must maintain patient records that include known allergies, drug reactions, and chronic conditions.

Medication error reporting is required for serious adverse events; pharmacies must have a continuous quality improvement program.

Pharmacists must use professional judgment in refusing to fill a prescription that appears fraudulent or unsafe and must document the refusal.

Patient confidentiality must be maintained in accordance with HIPAA and Arkansas law; unauthorized disclosure may result in discipline.

Arkansas pharmacists may administer immunizations to individuals of specified ages under a protocol or prescription, with training and certification requirements.

Vaccine administration must be reported to the Arkansas Immunization Information System (AR-IIS) within a specified time.

Pharmacists may participate in collaborative practice agreements with prescribers to manage chronic diseases under Board rules.

Naloxone may be dispensed by pharmacists under a standing order or protocol to persons at risk of opioid overdose.

Pharmacists must report adverse events following immunization to VAERS.

Pharmacists may provide emergency contraception and certain hormonal contraceptives under Arkansas protocols subject to Board rules.